Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Altamira Therapeutics Ltd (NQ: CYTO ) 1.395 +0.005 (+0.36%) Streaming Delayed Price Updated: 3:58 PM EDT, Jul 17, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 23,169 Open 1.400 Bid (Size) 1.380 (1) Ask (Size) 1.450 (20) Prev. Close 1.390 Today's Range 1.390 - 1.420 52wk Range 1.050 - 17.20 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Altamira Therapeutics Highlights Newly Published Review Article Supporting Use of Betahistine in Vertigo Management June 20, 2024 From Altamira Therapeutics Ltd Via GlobeNewswire Altamira Therapeutics Provides Business Update May 28, 2024 From Altamira Therapeutics Ltd Via GlobeNewswire Performance YTD -59.68% -59.68% 1 Month +12.50% +12.50% 3 Month -5.74% -5.74% 6 Month -43.29% -43.29% 1 Year -80.89% -80.89% More News Read More Hunting For Gains In Penny Stocks May 26, 2024 Via Talk Markets Biotechs Zero in on New Pancreatic Therapies as Global Pancreatic Cancer Market Expected Reach to $7.4 Billion By 2032 May 24, 2024 Via FinancialNewsMedia Topics Death Exposures Death Biotechs Zero in on New Pancreatic Therapies as Global Pancreatic Cancer Market Expected Reach to $7.4 Billion By 2032 May 24, 2024 From FN Media Group LLC Via GlobeNewswire 12 Health Care Stocks Moving In Thursday's Intraday Session May 23, 2024 Via Benzinga What's Going On With Altamira Therapeutics Stock? May 23, 2024 Via Benzinga Altamira Therapeutics Announces Dissemination of Positive Results from Bentrio Trial in Seasonal Allergic Rhinitis Through Social Media Channels of Top Allergy Journal May 23, 2024 From Altamira Therapeutics Ltd Via GlobeNewswire Altamira Therapeutics Announces Filing of Provisional Patent Application for OligoPhore Nanoparticles with siRNA Targeting p65 Protein in Treatment of Cancer and Inflammation May 01, 2024 From Altamira Therapeutics Ltd Via GlobeNewswire Altamira Therapeutics Announces Publication of Positive Results from Bentrio Trial in Seasonal Allergic Rhinitis in Top Peer Reviewed Journal April 24, 2024 From Altamira Therapeutics Ltd Via GlobeNewswire 12 Health Care Stocks Moving In Monday's Pre-Market Session April 22, 2024 Via Benzinga Altamira Therapeutics Provides Business Update, Reports Full Year 2023 Financial Results April 10, 2024 From Altamira Therapeutics Ltd Via GlobeNewswire Earnings Scheduled For April 10, 2024 April 10, 2024 Via Benzinga Altamira Therapeutics to Host Full Year 2023 Financial Results and Business Update Call on April 10, 2024 April 04, 2024 From Altamira Therapeutics Ltd Via GlobeNewswire Nasdaq Turns Higher; Akanda Shares Plunge March 25, 2024 Via Benzinga Topics Stocks Exposures US Equities 12 Health Care Stocks Moving In Monday's Intraday Session March 25, 2024 Via Benzinga Crude Oil Moves Higher; US New Home Sales Fall In February March 25, 2024 Via Benzinga Topics Stocks Exposures Fossil Fuels US Equities Why Landos Biopharma Shares Are Trading Higher By Over 170%? Here Are Other Stocks Moving In Monday's Mid-Day Session March 25, 2024 Via Benzinga Why Altamira Therapeutics Stock Is Racing Higher March 25, 2024 Via Benzinga US Stocks Down; Chicago Fed National Activity Index Rises In February March 25, 2024 Via Benzinga Topics Economy Stocks Exposures Interest Rates US Equities 12 Health Care Stocks Moving In Monday's Pre-Market Session March 25, 2024 Via Benzinga Altamira Therapeutics Announces Collaboration with Univercells Group on Nanoparticle-Delivered mRNA Vaccines March 25, 2024 From Altamira Therapeutics Ltd Via GlobeNewswire 12 Health Care Stocks Moving In Friday's Intraday Session March 01, 2024 Via Benzinga Altamira Therapeutics’ Peptide-Based Delivery Platform Shown to Enhance Potency of Commonly Used Gene Delivery Method as Published in Peer-Reviewed Journal February 07, 2024 From Altamira Therapeutics Ltd Via GlobeNewswire Altamira Therapeutics Files Second Provisional Patent Application for OligoPhore Nanoparticles Targeting Different KRAS Mutations in Cancer Treatment January 24, 2024 From Altamira Therapeutics Ltd Via GlobeNewswire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
